SLC2A1 and breast carcinoma: In addition, in breast cancer, the secretion of miR‐122 vesicles can downregulate GLUT1 and pyruvate kinase (PK) expression and reduce glucose uptake in nontumor cells, thereby increasing premetastatic cell nutrient availability and promoting metastasis.36